We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$1.71B
AUM Growth
-$31.5M
Cap. Flow
+$4.63M
Cap. Flow %
0.27%
Top 10 Hldgs %
83.44%
Holding
47
New
9
Increased
3
Reduced
4
Closed
7

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$166M
2
META icon
Meta Platforms (Facebook)
META
+$69.7M
3
AFRM icon
Affirm
AFRM
+$22.1M
4
SANA icon
Sana Biotechnology
SANA
+$14.6M
5
TNYA icon
Tenaya Therapeutics
TNYA
+$14.5M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$91.3M
2
ICE icon
Intercontinental Exchange
ICE
+$81.7M
3
AAPL icon
Apple
AAPL
+$81.2M
4
DVA icon
DaVita
DVA
+$49.2M
5
U icon
Unity
U
+$20.5M

Sector Composition

Rank Sector Weight
1 Healthcare 34.02%
2 Communication Services 23.75%
3 Technology 15.62%
4 Consumer Discretionary 13.04%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNGX icon
26
Tango Therapeutics
TNGX
$4.78B
$9.16M 0.54%
+708,385
New +$8.49M
VEA icon
27
Vanguard FTSE Developed Markets ETF
VEA
$234B
$8.21M 0.48%
162,699
– –
PACB icon
28
Pacific Biosciences
PACB
$447M
$5.86M 0.34%
+229,144
New +$6.79M
SRZN icon
29
Surrozen
SRZN
$255M
$5.85M 0.34%
+55,123
New +$7.76M
IJR icon
30
iShares Core S&P Small-Cap ETF
IJR
$113B
$5.41M 0.32%
49,559
-915
-2% -$101K
PRDS
31
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$3.98M 0.23%
400,000
– –
VWO icon
32
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$3.69M 0.22%
73,804
– –
IJH icon
33
iShares Core S&P Mid-Cap ETF
IJH
$126B
$3.34M 0.2%
63,415
– –
DBTX
34
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$2.54M 0.15%
328,798
– –
DNTH icon
35
Dianthus Therapeutics
DNTH
$6.04B
$2.42M 0.14%
20,788
– –
DYN icon
36
Dyne Therapeutics
DYN
$4.85B
$1.74M 0.1%
107,252
– –
IRON icon
37
Disc Medicine
IRON
$2.99B
$1.01M 0.06%
8,333
– –
MCRB icon
38
Seres Therapeutics
MCRB
$50.8M
$918K 0.05%
6,592
– –
SRZNW icon
39
Surrozen Inc Warrant
SRZNW
$69.7K
$124K 0.01%
+108,333
New +$149K
AMPL icon
40
Amplitude
AMPL
$1.31B
$29K ﹤0.01%
+540
New +$29.4K
DVA icon
41
DaVita
DVA
$14.6B
– –
-408,912
Closed -$49.2M
ICE icon
42
Intercontinental Exchange
ICE
$83.8B
– –
-688,549
Closed -$81.7M
NCNA
43
NuCana
NCNA
$5.79M
– –
-77
Closed -$1.07M
PANW icon
44
Palo Alto Networks
PANW
$299B
– –
-1,475,658
Closed -$91.3M
PDD icon
45
Pinduoduo
PDD
$130B
– –
-25,493
Closed -$3.24M
QNCX icon
46
Quince Therapeutics
QNCX
$26.8M
– –
-15
Closed -$156K
U icon
47
Unity
U
$15.4B
– –
-186,396
Closed -$20.5M
1
2

Similar funds

DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

Harvard Management Company's Q3 2021 Portfolio in Review

As of Q3 2021, Harvard Management Company held 47 positions worth $1.71B, down 1.8% from $1.74B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Harvard Management Company's Q3 2021 filing shows 9 new, 3 increased, 4 reduced and 7 closed positions. Its largest new stake was Alphabet (Google) Class A: 1,221,400 shares worth $163M. The largest sale was Palo Alto Networks, an estimated $91.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 38% a quarter earlier, followed by Communication Services and Technology.

  • Harvard Management Company's largest Q3 2021 buy was Alphabet (Google) Class A: 1,221,400 shares worth $163M.
  • Harvard Management Company added most to Meta Platforms (Facebook) in Q3 2021, an estimated $69.7M increase.
  • Harvard Management Company's biggest Q3 2021 reduction was Apple, cutting an estimated $81.2M.
  • Harvard Management Company fully exited Palo Alto Networks in Q3 2021, selling an estimated $91.3M.
  • Harvard Management Company's ten largest holdings make up 83% of its $1.71B portfolio in Q3 2021.
  • Harvard Management Company opened 9 new positions and closed 7 in Q3 2021.
  • Harvard Management Company's portfolio value fell 1.8% quarter-over-quarter to $1.71B.

Based on Harvard Management Company's 13F filing for Q3 2021, filed 12 Nov 2021.